Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

Nonbloody vaginal discharge can also be a manifestation of endometrial carcinoma and occurs in approximately 10% of patients. Pelvic pain and/or mass and weight loss usually occur in the later ...

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but missing out on overall survival.

Co., Inc. (NYSE:MRK) and Eisai Co., Ltd. (TYO:4523) have announced the latest outcomes from their Phase 3 LEAP-015 trial, which evaluated the efficacy of the combination therapy KEYTRUDA and LENVIMA ...

Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of esophageal cancer in a late-stage trial. The trial was studying Merck's ...

Light spotting after menopause can be caused by a few different things, including non-cancerous polyps, vaginal dryness, or excess growth of the tissue that lines the uterus. Less common causes range ...

sacituzumab tirumotecan (SKB-264) is under development for the treatment of ovarian epithelial cancer, gastric adenocarcinoma, triple negative breast cancer, endometrial carcinoma, HER2 negative ...

Purpose: To evaluate the effectiveness of magnetic resonance imaging (MRI)-based intratumoral and peritumoral radiomics models for predicting deep myometrial invasion (DMI) of early-stage endometrioid ...